Binds medium- and long-chain acyl-CoA esters.
Acyl-CoA-binding domain-containing protein 5-B (acbd5b) is a protein expressed in zebrafish (Danio rerio), which serves as a crucial component in cellular membrane contact sites. The significance of acbd5b lies in its role as a peroxisomal membrane protein that forms tethering complexes with the endoplasmic reticulum (ER) through interaction with VAPB (vesicle-associated membrane protein-associated protein B) . This tethering mechanism is essential for lipid metabolism and transfer between organelles. Zebrafish provide an excellent model for studying this protein due to their genetic similarity to humans, with approximately 70% shared genes and more than 84% of the genes that cause genetic disease in humans .
For optimal storage and handling of recombinant Danio rerio acbd5b:
Store the protein at -20°C for routine use, or at -80°C for extended storage periods
Use a Tris-based buffer with 50% glycerol optimized for protein stability
Avoid repeated freezing and thawing cycles as this can compromise protein integrity
For working aliquots, store at 4°C for up to one week
When conducting experiments, maintain protein samples on ice to minimize degradation
These conditions help preserve the structural integrity and functionality of the recombinant protein for experimental applications.
To generate CRISPR-based mutants of acbd5b in Danio rerio, researchers typically follow this methodology:
gRNA Design: Use tools like CHOPCHOP online database (https://chopchop.cbu.uib.no) to identify optimal guide RNA sequences targeting the acbd5b gene
Injection Protocol: Microinject CRISPR components (Cas9/Cas12a enzyme + gRNA) into one-cell stage zebrafish embryos
F0 Screening: Analyze F0 crispant embryos for mutations using fragment analysis to detect indels
Founder Identification: Fin clip adult F0 fish and screen for the presence of indels using fragment analysis
Germline Transmission: Outcross F0 carriers to generate F1 heterozygotes
Mutation Characterization: Sequence F1 embryo DNA via direct PCR and TOPO cloning to identify specific mutations
Stable Line Establishment: Raise F1 carriers to establish stable mutant lines
Fragment analysis using platforms like the Agilent 5300 Fragment Analyzer can detect indels as small as 2 base pairs with high resolution, making it particularly effective for screening potential mutants .
The interaction between acbd5b and VAPB at peroxisome-ER membrane contact sites is regulated through a complex phosphorylation mechanism:
Phosphorylation Sites: Multiple phosphorylation sites exist within the FFAT-like motif of acbd5b and its flanking regions
Differential Regulation: Phosphorylation at different sites within the FFAT-like motif can either enhance or inhibit binding to VAPB
Kinase Involvement: GSK3β (glycogen synthase kinase-3 beta) has been identified as a key regulator of this interaction
Mechanistic Model:
This phosphoregulation provides a dynamic mechanism for controlling the formation and dissolution of peroxisome-ER contacts in response to cellular needs. Experiments using phosphatase inhibitors and site-directed mutagenesis of phosphorylation sites demonstrate significant changes in binding affinity and contact site formation .
Studying acbd5b function through zebrafish behavioral assays requires a methodical approach:
Novel Tank Test: This assay evaluates anxiety-like behaviors that might result from peroxisomal dysfunction
Social Preference Test: As lipid metabolism affects neurological development:
Experimental Design Considerations:
Data Analysis:
These behavioral paradigms can reveal phenotypes resulting from disrupted lipid metabolism due to acbd5b dysfunction, particularly in the context of neurodevelopmental processes.
Real-time visualization of acbd5b-mediated peroxisome-ER contact sites in zebrafish can be achieved through several advanced imaging techniques:
Fluorescent Protein Tagging:
FRET-Based Approaches:
Create donor-acceptor pairs using acbd5b-CFP and VAPB-YFP
Measure FRET efficiency to quantify protein-protein interactions
Changes in FRET signal upon phosphatase or kinase inhibitor treatment reveal regulatory mechanisms
Split-GFP Complementation:
Express one GFP fragment fused to acbd5b and the complementary fragment fused to VAPB
GFP fluorescence only occurs when proteins interact, creating contact sites
Quantify fluorescence intensity to measure contact site abundance
Live Imaging in Zebrafish Embryos:
These approaches, combined with pharmacological interventions targeting GSK3β or other regulatory kinases, provide insights into the spatial and temporal dynamics of peroxisome-ER contacts mediated by acbd5b.
The function of acbd5b shows important differences between in vitro biochemical studies and in vivo zebrafish models:
| Parameter | In Vitro Biochemical Assays | In Vivo Zebrafish Models |
|---|---|---|
| Binding Kinetics | Direct measurement of acbd5b-VAPB binding affinities using purified proteins | Complex interactions influenced by cellular environment and competing binding partners |
| Phosphorylation | Controlled phosphorylation states using purified kinases/phosphatases | Dynamic regulation through multiple signaling pathways |
| Organelle Dynamics | Static assessment of binding using fixed concentrations | Dynamic remodeling of organelle contacts in response to metabolic demands |
| Functional Outcomes | Limited to molecular interactions | Observable phenotypic consequences (development, behavior, metabolism) |
| Temporal Resolution | Snapshot measurements | Developmental timeline from embryo to adult |
| Genetic Compensation | Absent | Potential upregulation of paralogous genes in response to acbd5b mutation |
To bridge these differences, researchers employ complementary approaches:
Validate in vitro findings using cell culture systems from zebrafish tissues
Correlate biochemical measurements with in vivo phenotypes
Use pharmacological interventions in vivo to target specific aspects of acbd5b function identified in vitro
Develop zebrafish lines expressing modified forms of acbd5b (phosphomimetic or phospho-dead mutations) to test hypotheses derived from biochemical studies
When faced with contradictory data regarding acbd5b function across different experimental systems, researchers can employ these methodological approaches:
Systematic Comparison of Experimental Conditions:
Create a standardized matrix of experimental variables (temperature, buffer composition, protein concentrations)
Identify critical parameters that influence experimental outcomes
Develop a consensus protocol that minimizes variability
Cross-Validation Across Multiple Systems:
Test hypotheses in parallel using:
In vitro biochemical assays with purified components
Cell culture models (both mammalian and fish cell lines)
Zebrafish embryos at different developmental stages
Adult zebrafish behavioral and physiological studies
Genetic Approach to Resolve Discrepancies:
Generate allelic series of acbd5b mutations (null, hypomorphic, phospho-mutants)
Create tissue-specific and inducible knockouts to distinguish primary from secondary effects
Perform rescue experiments with wild-type or modified acbd5b to verify specificity
Collaborative Multi-laboratory Validation:
Advanced Statistical Approaches:
These approaches help identify whether contradictions arise from technical factors, biological variables, or fundamental differences in the systems being studied.
To develop targeted modulators of acbd5b activity for experimental applications, researchers can implement the following methodological approaches:
Structure-Based Design of Peptide Inhibitors:
Synthesize peptides mimicking the FFAT-like motif of acbd5b
Introduce modifications to enhance cell permeability (e.g., TAT sequence fusion)
Test competitive inhibition of acbd5b-VAPB interactions in cell-free and cellular systems
Small Molecule Screening:
Establish high-throughput binding assays using fluorescence polarization
Screen compound libraries for molecules that modulate acbd5b-VAPB interaction
Validate hits using secondary assays including cellular peroxisome-ER contacts
Genetic Modulators:
Design dominant-negative forms of acbd5b that retain binding capacity but lack functional domains
Develop photoactivatable variants using optogenetic approaches for temporal control
Create FKBP-FRB fusion systems for chemically-inducible dimerization to control contact site formation
Kinase/Phosphatase Targeting:
Use GSK3β inhibitors to modulate acbd5b phosphorylation state
Apply phosphatase inhibitors to maintain phosphorylated states
Develop site-specific approaches targeting only the relevant phosphorylation sites
Validation in Zebrafish Models: